𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression

✍ Scribed by Iman Osman; Jie Dai; Maryann Mikhail; Daniel Navarro; Samir S. Taneja; Peng Lee; Paul Christos; Ruoqian Shen; David M. Nanus


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
347 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Celecoxib-induced growth inhibition in S
✍ Jae-Won Soh; Julhash U. Kazi; Han Li; W. Joseph Thompson; I. Bernard Weinstein πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 161 KB

## Abstract Although it is often assumed that the antitumor effects of nonsteroidal anti‐inflammatory drugs (NSAIDs) are due to inhibition of cyclooxgenase (COX) activity, specifically COX‐2, there is accumulating evidence that COX‐2 independent mechanisms can also play an important role. Studies w

Prostate cancer cell growth inhibition b
✍ Rohlff, Christian; Blagosklonny, Mikhail V.; Kyle, Edward; Kesari, Anuradha; Yi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 408 KB πŸ‘ 2 views

BACKGROUND. Inhibition of protein kinase C (PKC) and modulation of transforming growth factor-␀ (TGF-␀) are both associated with tamoxifen treatment, and both appear to be important in the regulation of prostate cancer cell growth. Investigations were performed which sought to measure the efficacy,

Elevation of serum levels of urokinase-t
✍ Miyake, Hideaki; Hara, Isao; Yamanaka, Kazuki; Gohji, Kazuo; Arakawa, Soichi; Ka πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 1 views

BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a

Curcumin-induced antiproliferative and p
Increased expression of cyclin-dependent
✍ Ying Dong; Michael D. Walsh; Michael A. McGuckin; Brian B. Gabrielli; Margaret C πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 336 KB πŸ‘ 2 views

Paraffin sections from 190 epithelial ovarian tumours, including 159 malignant and 31 benign epithelial tumours, were analysed immunohistochemically for expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16 INK4A (p16). Most benign tumours showed no p16 expression in the tumour